Expansion Therapeutics raises a $55,300,000 series A round from 5AM Ventures, Kleiner Perkins Caufield & Byers, Novartis Venture Fund, RA Capital Management and Sanofi Ventures.
Documentaries, videos and podcasts
May 25, 2021
Expansion Therapeutics, Inc., a biotechnology company advancing transformative medicines to patients with RNA-mediated diseases, today announced the in-licensing of two new research programs from Scripps Research. One program targets tau, a key driver of dementia disorders
May 6, 2021
Expansion Therapeutics Names Valerie Cullen, Ph.D., Senior Vice President of Research - read this article along with other careers information, tips and advice on BioSpace